GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Relief Therapeutics Holding SA (OTCPK:RLFTY) » Definitions » Days Payable

RLFTY (Relief Therapeutics Holding) Days Payable : 262.58 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Relief Therapeutics Holding Days Payable?

Relief Therapeutics Holding's average Accounts Payable for the six months ended in Dec. 2024 was $1.63 Mil. Relief Therapeutics Holding's Cost of Goods Sold for the six months ended in Dec. 2024 was $1.14 Mil. Hence, Relief Therapeutics Holding's Days Payable for the six months ended in Dec. 2024 was 262.58.

The historical rank and industry rank for Relief Therapeutics Holding's Days Payable or its related term are showing as below:

RLFTY' s Days Payable Range Over the Past 10 Years
Min: 22.89   Med: 574   Max: 24151.69
Current: 186.3

During the past 13 years, Relief Therapeutics Holding's highest Days Payable was 24151.69. The lowest was 22.89. And the median was 574.00.

RLFTY's Days Payable is ranked better than
59.97% of 707 companies
in the Biotechnology industry
Industry Median: 124.08 vs RLFTY: 186.30

Relief Therapeutics Holding's Days Payable declined from Dec. 2023 (296.58) to Dec. 2024 (262.58). It may suggest that Relief Therapeutics Holding accelerated paying its suppliers.


Relief Therapeutics Holding Days Payable Historical Data

The historical data trend for Relief Therapeutics Holding's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relief Therapeutics Holding Days Payable Chart

Relief Therapeutics Holding Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.53 29.39 488.57 266.34 190.21

Relief Therapeutics Holding Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 489.94 438.53 296.58 137.32 262.58

Competitive Comparison of Relief Therapeutics Holding's Days Payable

For the Biotechnology subindustry, Relief Therapeutics Holding's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Relief Therapeutics Holding's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Relief Therapeutics Holding's Days Payable distribution charts can be found below:

* The bar in red indicates where Relief Therapeutics Holding's Days Payable falls into.


;
;

Relief Therapeutics Holding Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Relief Therapeutics Holding's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

Days Payable (A: Dec. 2024 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2023 ) + Accounts Payable (A: Dec. 2024 )) / count ) / Cost of Goods Sold (A: Dec. 2024 )*Days in Period
=( (1.185 + 1.825) / 2 ) / 2.888*365
=1.505 / 2.888*365
=190.21

Relief Therapeutics Holding's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

Days Payable (Q: Dec. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2024 ) + Accounts Payable (Q: Dec. 2024 )) / count ) / Cost of Goods Sold (Q: Dec. 2024 )*Days in Period
=( (1.444 + 1.825) / 2 ) / 1.136*365 / 2
=1.6345 / 1.136*365 / 2
=262.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Relief Therapeutics Holding Days Payable Related Terms

Thank you for viewing the detailed overview of Relief Therapeutics Holding's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Relief Therapeutics Holding Business Description

Traded in Other Exchanges
Address
Avenue de Secheron 15, Geneva, CHE, 1202
Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Its pipeline includes various drug candidates in their different stages of development such as RLF-TD011, and RLF-100, among others. It also has commercial legacy products like Cambia, Setofilm, Voltadol, and Voltfast among others. Geographically the company generates a majority of its revenue from Europe (excluding Switzerland) and the rest from North America, Switzerland, and the rest of the world.